A JAMA Network Open study of 2,316 patients in four cities found BMI couldn't separate clinical from preclinical obesity. Authors see a role for drugs first in some cases.
Recap by typeshit. Full story at The American Journal of Managed Care.
German researchers made synthetic versions of peptides from axolotl skin mucus, and some slowed the growth of MRSA, the drug-resistant bacteria.
10:45
The nutrition and exercise graduate walks through her food picks for people on retatrutide, aimed at holding onto muscle during weight loss.
Experts say holding on to weight loss after quitting a GLP-1 is possible and walk through the habits they recommend for the transition.
The study of over 87,000 matched patients 65 and up also found 28% fewer liver decompensation events, but no drop in heart attack or stroke and more osteoporosis diagnoses.
U of T researchers built the AI tool with the aim of speeding up how new peptide drugs are found. The university's announcement has the details.
Fractyl plans to file a De Novo request with the FDA in late Q4, yet its shares closed about 63% lower that day over a class action and doubts about 12-month results.
Loading…